Telomere length, telomerase activity and telomerase RNA expression during mouse mammary tumor progression.
To investigate the roles of telomere length (mean length of the terminal restriction fragments; TRFs), telomerase activity (TA) and telomerase RNA (mTR) expression in relation to mouse mammary tumor progression, we examined a pregnancy-dependent mouse mammary tumor line (TPDMT-4) and its four autonomous sublines (T4-OI320: non-metastatic; and T4-OI165, -OI96, and -OI145: artificial metastatic) of DDD/1 mouse origin, and an autonomous growing mammary tumor (JYG-MC) showing spontaneous lung metastasis developed in BALB/c mice infected with a Chinese feral mice (Sub-Jyg)-derived mouse mammary tumor virus (JYG-MTV). Compared with normal (pregnant) mammary tissue, the TA was elevated in the TPDMT-4 tumor and in the non-metastatic subline tumor (T4-OI320) (x10 fold, respectively), and was further increased (x13-15 fold) in parallel with the acquisition of metastatic potential (T4-OI165, -OI96, and -OI145). The mTR level was upregulated (x2.7-2.8 fold) in all autonomous growing tumors compared to the normal counter-part, but not in TPDMT-4. The TRF was shorter in accord with tumor progression (normal mammary tissue, 48 kb; TPDMT-4, 45 kb; T4-OI320, 37 kb; T4-OI165, -OI96 and -OI145, mean 37.7 kb; and JYG-MC, 21 kb). These results suggest that the activation of TA occurs as an early event at the stage of hormone-dependent tumorigenesis, followed by the up-regulation of mTR expression in accordance with the acquisition of autonomous growth, and then further activation of TA occurs when the tumor acquires metastatic potential. The TRF shortening was in parallel with the tumor progression.
Kiyozuka
Y
Y
Department of Pathology II, Kansai Medical University, 10-15 Fumizono, Moriguchi, Osaka 570-8506, Japan.
Asai
A
A
Senzaki
H
H
Uemura
Y
Y
Nakashima
A
A
Morimoto
J
J
Matsuzawa
A
A
Tsubura
A
A
D000818:Animals; D005260:Female; D008175:Lung Neoplasms / Q000556:secondary; D008321:Mammary Glands, Animal / Q000201:enzymology; D008325:Mammary Neoplasms, Experimental / Q000201:enzymology* / Q000473:pathology / Q000648:ultrastructure; D051379:Mice; D009376:Neoplasms, Hormone-Dependent / Q000201:enzymology* / Q000473:pathology / Q000648:ultrastructure; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000201:enzymology / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis*; D019098:Telomerase / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism*; D016615:Telomere / Q000648:ultrastructure*
D012333:RNA, Messenger; D019098:Telomerase